US Pharma MarketingFacing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.
Intuitive’s US da Vinci procedure growth slows again
Intuitive’s US da Vinci procedure growth slows again is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive